Skip to content

Clinical trials

Rectal Neoplasms trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Rectal Neoplasms Country / region: Taiwan Clear all

33 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20032
20102
20111
20151
20162
20172
20201
20211
20224
20234
20243
20254
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting8
Completed8
Active, not recruiting7
Unknown status5
Not yet recruiting2
Enrolling by invitation2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chang Gung Memorial Hospital8
National Taiwan University Hospital6
Novartis Pharmaceuticals3
Taichung Veterans General Hospital3
Amgen1
China Medical University Hospital1
Eli Lilly and Company1
Jeng-Fu You1
Merck Sharp & Dohme LLC1
Mirati Therapeutics Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Rectal Neoplasms33
Colorectal Neoplasms11
Colonic Neoplasms10
Neoplasms5
Carcinoma, Non-Small-Cell Lung4
Intestinal Neoplasms4
Lung Neoplasms4
Esophageal Neoplasms3
Neoplasm Metastasis3
Ovarian Neoplasms3

Trials

Showing 51 to 33 of 33. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.